Phil Zamore
E446843
Phil Zamore is a molecular biologist and biotechnology entrepreneur best known as a co-founder of Alnylam Pharmaceuticals and a pioneer in the field of RNA interference therapeutics.
Statements (37)
| Predicate | Object |
|---|---|
| instanceOf |
academic
ⓘ
biotechnology entrepreneur ⓘ molecular biologist ⓘ scientist ⓘ |
| associatedWith |
Alnylam’s early scientific strategy
ⓘ
RNAi therapeutics industry ⓘ |
| coFounded | Alnylam Pharmaceuticals NERFINISHED ⓘ |
| countryOfCitizenship |
United States of America
ⓘ
surface form:
United States
|
| fieldOfWork |
RNA biology
ⓘ
RNA interference ⓘ RNA therapeutics NERFINISHED ⓘ gene silencing ⓘ molecular biology ⓘ |
| hasAcademicDiscipline |
RNA biochemistry
ⓘ
biochemistry ⓘ molecular genetics ⓘ |
| hasContribution |
elucidation of biochemical steps in RNAi pathways
ⓘ
translation of RNAi from basic science to drug development ⓘ |
| hasNotableStudentOrTrainee | RNA interference researchers ⓘ |
| hasOccupation |
biotech founder
ⓘ
professor ⓘ research scientist ⓘ |
| hasRole | co-founder of Alnylam Pharmaceuticals ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| influenced | development of RNAi as a therapeutic modality ⓘ |
| knownFor |
co-founding Alnylam Pharmaceuticals
ⓘ
pioneering work in RNA interference therapeutics ⓘ |
| languageOfWorkOrName | English ⓘ |
| notableFor |
contributions to the mechanism of RNA interference
ⓘ
development of RNAi-based therapeutics ⓘ early academic research on RNA interference ⓘ helping establish RNAi as a platform for human therapeutics ⓘ |
| researchInterest |
microRNA
ⓘ
post-transcriptional gene regulation ⓘ small interfering RNA ⓘ |
| workLocation |
United States of America
ⓘ
surface form:
United States
|
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.